Cluster Headache Market Size, By Type (Episodic, Chronic), By Drug Type (Fast-acting Drugs, Long-term Drugs, Short-term Drugs), By Route of Administration (Oral, Topical, Intravenous, Others), By Distribution Channel Industry (Hospital Pharmacies, Retail Pharmacies, Online, Pharmacies) - Global Forecasts 2018 - 2030

Published on 03/02/2022| Code: CMM460001| Category: Healthcare & Life Sciences| Total Pages: 189

The Global Cluster Headache Market Overview:

Cluster headache, which is a neurological disorder, is characterized by severe headaches that recur on the opposite face, typically around the eyes. It is usually caused by autonomic issues like excessive tears as well as swelling of the eyes and nasal congestion. In the case of cluster headache syndrome, patients often suffer from painful headaches that are unilateral. Certain symptoms of migraine, like sensitivity to light and sound nausea, could also occur in the cluster headache.

The causes of headache clusters aren't fully understood, although some uncommon causes could be genetic, smoking or dysfunction of the hypothalamus. The severe pain is thought to be due to an increase in blood vessel size, which creates tension on the trigeminal nerve. The diagnosis of the syndrome known as cluster headache can be a bit misleading, poorly managed and wrongly diagnosed.

The headaches that cause clusters of pain typically occur several times during a day, and each attack lasts no more than three hours with no treatment. The attacks can occur every day for a period of weeks or months before they diminish for a time, although they may persist for months or even years for some individuals. The prevalence of cluster headaches among males is between three and four times higher than that of women. Chronic and episodic are two forms of cluster headaches.

Contrary to chronic cluster headaches, episodic headaches are distinguished by the relatively long and pain-free remissions in between headaches. A little over 10 percent of patients who suffer from headache clusters are suffering from the chronic syndrome. Examining the eyes can help physicians identify the indications of cluster headaches. For example, one pupil may appear smaller than the other or may droop on the eyelids.

Market Drivers and Market Restraints for the Global Cluster Headache Market:

The global market for cluster headache syndrome has been driven by the ageing population, rising prevalence and frequency of cluster headache syndrome, and technological advancements in healthcare. An increase in disposable income levels, as well as increasing awareness of health issues among the general population, has led to an increase in the frequency of diagnosis for cluster headaches. In addition, an increase in TV viewing and the use of computers has been a factor in the rise of cluster headache syndrome. But the lack of understanding of healthcare professionals, lack of awareness among the public and measures taken by the government to cut healthcare costs are major obstacles to effective treatment in the market for cluster headache syndrome.

Global Cluster Headache Market: Overview

As per Credible Markets Insights, the global market for cluster headaches is expected to be worth US$355.2 Million in 2021. It is anticipated to exhibit a CAGR of 6.4% during the forecast time (2021-2028).

Preventive measures help reduce or completely eliminate cluster headaches. Verapamil is an inhibitor of calcium channels, is the most recommended first-line treatment for cluster headache syndrome. Steroids can also be utilized together with other drugs and can be discontinued within 8-10 days after treatment. Preventive surgery may include stimulation of the nerves in patients who are not responding to the medication.

TENS, or transcutaneous electrical nerve stimulation (TENS) is a non-invasive treatment currently under investigation for treating cluster headaches. Other preventive options that are recommended for cluster headache syndrome are methysergide, lithium and topiramate. The primary treatment for cluster headaches that are acute is the use of oxygen as well as the subcutaneous and intranasal route of sumatriptan. Sumatriptan injections can decrease pain within 10 minutes. Vasoconstricting agents like Ergot can also help with cluster headache syndrome.

Market Dynamics: Market Value Share Analysis

Cluster Headache Syndrome Market: Region-Wise Outlook:

Within the various regions, North America dominates the world market for cluster headaches because of the modern healthcare infrastructure, as well as the development of new technologies to detect the condition and the rising incidence of migraines.

Asia Pacific is expected to be the fastest-growing region and the highest CAGR over the forecast period. This is due in part to an increase in expenditure on health infrastructure development as well as the growing geriatric population.

Cluster Headache Syndrome Market: Drug Type Outlook:

Among the drug type that are fast-acting, they hold an undisputed position in the market for cluster headaches in the world. Corticosteroids, which are anti-inflammatory drugs like prednisone, are preventive drugs that act quickly and can be beneficial for many sufferers of cluster headaches.

Competitive Landscape:

The key players who contribute to the global market for cluster headache syndrome include Autonomic Technologies, Inc., GlaxoSmithKline plc, Winston Pharmaceuticals, Inc., AstraZeneca plc, ElectroCore Medical LLC etc.

A comprehensive analysis of the market has been provided by the research report. It also contains well-thought-out insights, facts as well as historical data. The most reliable and accurate market information. It also provides projections that are based on an appropriate set of assumptions and methods. The report offers data and analysis based on various categories like geographies, market segments, technology, types and applications.

Key Benefits for Stakeholders:

The report offers a comprehensive analysis of current and emerging global market for Global Cluster Headache Market trends and dynamics.
An extensive research of markets is carried out through the constructing market estimates for the most important segments of the market between 2021 and 2028.
A comprehensive study of market trends is done through the analysis of key positioning for products and monitoring the leading competitors within the framework of the market.
An extensive analysis of each region is offered to help determine the current market opportunities for Global Cluster Headache Market.
The main key players within the market are profiled in this report, and their strategies are extensively analyzed and it helps to determine the future competitive landscape of the market.

The Key Market Segmentation of the Global Cluster Headache Market:

This Research Report Categorized The Global Organic Yeast Market Based on Types, Drug Types, Mechanism of Action, Diagnosis, Treatment, Route of Administration, End-User and Geographical Landscape.

Cluster Headache Market Segmentation By Types:
Episodic
Chronic

Cluster Headache Market Segmentation By Drug Type:
Calcium channel blockers
Corticosteroids
Sumatriptan
Lithium carbonate
Ergots
Melatonin
Anti-seizure
Local anesthetics

Cluster Headache Market Segmentation By Mechanism of Action:
Corticosteroids,
Ergot Alkaloids,
Local Anaesthetics,
Calcium Channel Blockers,
Triptans,
Lithium Carbonate,
Anti-Seizures

Cluster Headache Market Segmentation By Diagnosis:
Neurological Examination
MRI
CT scan

Cluster Headache Market Segmentation By Treatment:
Medication
Surgery

Cluster Headache Market Segmentation By Route of Administration:
Oral
Topical
Intravenous
Others

Cluster Headache Market Segmentation By End-User:
Hospitals,
Homecare,
Specialty Clinics,
Others.

Cluster Headache Market Segmentation By Geographical Landscape:
North America
Europe
Asia Pacific
South America
Middle East and Africa

Key Market Players In The Cluster Headache Market:

• Zosano Pharma
• Eli Lilly and Company
• ElectroCore Medical LLC
• Autonomic Technologies, Inc.
• Sun Pharmaceutical Industries Ltd
• Lundbeck Seattle BioPharmaceutical
• Winston Laboratories
• GlaxoSmithKline plc.
• Teva Pharmaceutical Industries Ltd.
• Takeda Pharmaceutical Company Limited
• AstraZeneca plc.
• Allergan plc.
• Bayer AG, F. Hoffmann-La Roche Ltd
• Novartis AG
• Sanofi
• AbbVie Inc.

1. Executive Summary
1.1. Global Cluster Headache Market Snapshot
1.2. Global Cluster Headache Market Taxonomy
1.3. Global Cluster Headache Market Introduction

2. Market Segmentation
2.1. Global Cluster Headache Market, by Type
2.1.1. Episodic
2.1.2. Chronic
2.2. Global Cluster Headache Market, by Drug Type
2.2.1. Fast-acting Drugs
2.2.2. Long-term Drugs
2.2.3. Short-term Drugs
2.3. Global Cluster Headache Market, by Route of Administration
2.3.1. Oral
2.3.2. Topical
2.3.3. Intravenous
2.3.4. Others
2.4. Global Cluster Headache Market, by Distribution Channel Industry
2.4.1. Hospital Pharmacies
2.4.2. Retail Pharmacies
2.4.3. Online Pharmacies

3. Market Dynamics
3.1. Driving Factors
3.2. Restraints
3.3. Opportunities
3.4. Recent Trends
3.5. PROTER’S Five Analysis
3.6. PEST Analysis
3.7. COVID-19 Impacts on industry

4. Global Cluster Headache Market overview
4.1. Global Cluster Headache Market Value (US$ Mn), 2018-2030
4.2. Global Cluster Headache Market Incremental Opportunity (US$ Mn), 2018-2030
4.3. Global Cluster Headache Market Outlook, By Type
4.3.1. Global Cluster Headache Market share % By Type, 2016-2020-2028
4.3.2. Global Cluster Headache Market Value (US$ Mn), By Type, 2018-2030
4.3.3. Global Cluster Headache Market Value (US$ Mn), By Type, Table, 2018-2030
4.3.4. Global Cluster Headache Market share (%), By Type, Table, 2018-2030
4.4. Global Cluster Headache Market Outlook, By Drug Type
4.4.1. Global Cluster Headache Market share % By Drug Type, 2016-2020-2028
4.4.2. Global Cluster Headache Market Value (US$ Mn), By Drug Type, 2018-2030
4.4.3. Global Cluster Headache Market Value (US$ Mn), By Drug Type, Table, 2018-2030
4.4.4. Global Cluster Headache Market share (%), By Drug Type, Table, 2018-2030
4.5. Global Cluster Headache Market Outlook, By Route of Administration
4.5.1. Global Cluster Headache Market share % By Route of Administration, 2016-2020-2028
4.5.2. Global Cluster Headache Market Value (US$ Mn), By Route of Administration, 2018-2030
4.5.3. Global Cluster Headache Market Value (US$ Mn), By Route of Administration, Table, 2018-2030
4.5.4. Global Cluster Headache Market share (%), By Route of Administration, Table, 2018-2030
4.6. Global Cluster Headache Market Outlook, By Distribution Channel
4.6.1. Global Cluster Headache Market share % By Distribution Channel, 2016-2020-2028
4.6.2. Global Cluster Headache Market Value US$ Mn, By Distribution Channel, 2018-2030
4.6.3. Global Cluster Headache Market Value (US$ Mn), By Distribution Channel, Table, 2018-2030
4.6.4. Global Cluster Headache Market share (%), By Distribution Channel, Table, 2018-2030
4.7. Global Cluster Headache Market Outlook, by Region
4.7.1. Global Cluster Headache Market share % by Region, 2016-2020-2028
4.7.2. Global Cluster Headache Market Value US $Mn, By Region, 2018-2030
4.7.3. Global Cluster Headache Market Value (US$ Mn), By Region, Table, 2018-2030
4.7.4. Global Cluster Headache Market share (%), By Region, Table, 2018-2030

5. North America Cluster Headache Market Overview
5.1. North America Cluster Headache Market Value (US$ Mn), 2018-2030
5.2. North America Cluster Headache Market Incremental Opportunity (US$ Mn), 2018-2030
5.3. North America Cluster Headache Market Outlook, By Type
5.3.1. North America Cluster Headache Market share % By Type, 2016-2020-2028
5.3.2. North America Cluster Headache Market Value US$ Mn, By Type, 2018-2030
5.3.3. North America Cluster Headache Market Value (US$ Mn), By Type, Table, 2018-2030
5.3.4. North America Cluster Headache Market share (%), By Type, Table, 2018-2030
5.4. North America Cluster Headache Market Outlook, By Drug Type
5.4.1. North America Cluster Headache Market share % By Drug Type, 2016-2020-2028
5.4.2. North America Cluster Headache Market Value US$ Mn, By Drug Type, 2018-2030
5.4.3. North America Cluster Headache Market Value (US$ Mn), By Drug Type, Table, 2018-2030
5.4.4. North America Cluster Headache Market share (%), By Drug Type, Table, 2018-2030
5.5. North America Cluster Headache Market Outlook, By Route of Administration
5.5.1. North America Cluster Headache Market share % By Route of Administration, 2016-2020-2028
5.5.2. North America Cluster Headache Market Value US$ Mn, By Route of Administration, 2018-2030
5.5.3. North America Cluster Headache Market Value (US$ Mn), By Route of Administration, Table, 2018-2030
5.5.4. North America Cluster Headache Market share (%), By Route of Administration, Table, 2018-2030
5.6. North America Cluster Headache Market Outlook, By Distribution Channel
5.6.1. North America Cluster Headache Market share % By Distribution Channel, 2016-2020-2028
5.6.2. North America Cluster Headache Market Value US$ Mn, By Distribution Channel, 2018-2030
5.6.3. North America Cluster Headache Market Value (US$ Mn), By Distribution Channel, Table, 2018-2030
5.6.4. North America Cluster Headache Market share (%), By Distribution Channel, Table, 2018-2030
5.7. North America Cluster Headache Market Outlook, by Country
5.7.1. North America Cluster Headache Market share % by Country, 2016-2020-2028
5.7.2. North America Cluster Headache Market Value US$ Mn, By Country, 2018-2030
5.7.3. North America Cluster Headache Market Value (US$ Mn), By Country, Table, 2018-2030
5.7.4. North America Cluster Headache Market share (%), By Country, Table, 2018-2030

6. Europe Cluster Headache Market Overview
6.1. Europe Cluster Headache Market Value (US$ Mn), 2018-2030
6.2. Europe Cluster Headache Market Incremental Opportunity (US$ Mn), 2018-2030
6.3. Europe Cluster Headache Market Outlook, By Type
6.3.1. Europe Cluster Headache Market share % By Type, 2016-2020-2028
6.3.2. Europe Cluster Headache Market Value US$ Mn, By Type, 2018-2030
6.3.3. Europe Cluster Headache Market Value (US$ Mn), By Type, Table, 2018-2030
6.3.4. Europe Cluster Headache Market share (%), By Type, Table, 2018-2030
6.4. Europe Cluster Headache Market Outlook, By Drug Type
6.4.1. Europe Cluster Headache Market share % By Drug Type, 2016-2020-2028
6.4.2. Europe Cluster Headache Market Value US$ Mn, By Drug Type, 2018-2030
6.4.3. Europe Cluster Headache Market Value (US$ Mn), By Drug Type, Table, 2018-2030
6.4.4. Europe Cluster Headache Market share (%), By Drug Type, Table, 2018-2030
6.5. Europe Cluster Headache Market Outlook, By Route of Administration
6.5.1. Europe Cluster Headache Market share % By Route of Administration, 2016-2020-2028
6.5.2. Europe Cluster Headache Market Value US$ Mn, By Route of Administration, 2018-2030
6.5.3. Europe Cluster Headache Market Value (US$ Mn), By Route of Administration, Table, 2018-2030
6.5.4. Europe Cluster Headache Market share (%), By Route of Administration, Table, 2018-2030
6.6. Europe Cluster Headache Market Outlook, By Distribution Channel
6.6.1. Europe Cluster Headache Market share % By Distribution Channel, 2016-2020-2028
6.6.2. Europe Cluster Headache Market Value US$ Mn, By Distribution Channel, 2018-2030
6.6.3. Europe Cluster Headache Market Value (US$ Mn), By Distribution Channel, Table, 2018-2030
6.6.4. Europe Cluster Headache Market share (%), By Distribution Channel, Table, 2018-2030
6.7. Europe Cluster Headache Market Outlook, by Country
6.7.1. Europe Cluster Headache Market share % by Country, 2016-2020-2028
6.7.2. Europe Cluster Headache Market Value US$ Mn, By Country, 2018-2030
6.7.3. Europe Cluster Headache Market Value (US$ Mn), By Country, Table, 2018-2030
6.7.4. Europe Cluster Headache Market share (%), By Country, Table, 2018-2030

7. Asia Pacific Cluster Headache Market Overview
7.1. Asia Pacific Cluster Headache Market Value (US$ Mn), 2018-2030
7.2. Asia Pacific Cluster Headache Market Incremental Opportunity (US$ Mn), 2018-2030
7.3. Asia Pacific Cluster Headache Market Outlook, By Type
7.3.1. Asia Pacific Cluster Headache Market share % By Type, 2016-2020-2028
7.3.2. Asia Pacific Cluster Headache Market Value US$ Mn, By Type, 2018-2030
7.3.3. Asia Pacific Cluster Headache Market Value (US$ Mn), By Type, Table, 2018-2030
7.3.4. Asia Pacific Cluster Headache Market share (%), By Type, Table, 2018-2030
7.4. Asia Pacific Cluster Headache Market Outlook, By Drug Type
7.4.1. Asia Pacific Cluster Headache Market share % By Drug Type, 2016-2020-2028
7.4.2. Asia Pacific Cluster Headache Market Value US$ Mn, By Drug Type, 2018-2030
7.4.3. Asia Pacific Cluster Headache Market Value (US$ Mn), By Drug Type, Table, 2018-2030
7.4.4. Asia Pacific Cluster Headache Market share (%), By Drug Type, Table, 2018-2030
7.5. Asia Pacific Cluster Headache Market Outlook, By Route of Administration
7.5.1. Asia Pacific Cluster Headache Market share % By Route of Administration, 2016-2020-2028
7.5.2. Asia Pacific Cluster Headache Market Value US$ Mn, By Route of Administration, 2018-2030
7.5.3. Asia Pacific Cluster Headache Market Value (US$ Mn), By Route of Administration, Table, 2018-2030
7.5.4. Asia Pacific Cluster Headache Market share (%), By Route of Administration, Table, 2018-2030
7.6. Asia Pacific Cluster Headache Market Outlook, By Distribution Channel
7.6.1. Asia Pacific Cluster Headache Market share % By Distribution Channel, 2016-2020-2028
7.6.2. Asia Pacific Cluster Headache Market Value US$ Mn, By Distribution Channel, 2018-2030
7.6.3. Asia Pacific Cluster Headache Market Value (US$ Mn), By Distribution Channel, Table, 2018-2030
7.6.4. Asia Pacific Cluster Headache Market share (%), By Distribution Channel, Table, 2018-2030
7.7. Asia Pacific Cluster Headache Market Outlook, by Country
7.7.1. Asia Pacific Cluster Headache Market share % by Country, 2016-2020-2028
7.7.2. Asia Pacific Cluster Headache Market Value US$ Mn, By Country, 2018-2030
7.7.3. Asia Pacific Cluster Headache Market Value (US$ Mn), By Country, Table, 2018-2030
7.7.4. Asia Pacific Cluster Headache Market share (%), By Country, Table, 2018-2030

8. South America Cluster Headache Market Overview
8.1. South America Cluster Headache Market Value (US$ Mn), 2018-2030
8.2. South America Cluster Headache Market Incremental Opportunity (US$ Mn), 2018-2030
8.3. South America Cluster Headache Market Outlook, By Type
8.3.1. South America Cluster Headache Market share % By Type, 2016-2020-2028
8.3.2. South America Cluster Headache Market Value US$ Mn, By Type, 2018-2030
8.3.3. South America Cluster Headache Market Value (US$ Mn), By Type, Table, 2018-2030
8.3.4. South America Cluster Headache Market share (%), By Type, Table, 2018-2030
8.4. South America Cluster Headache Market Outlook, By Drug Type
8.4.1. South America Cluster Headache Market share % By Drug Type, 2016-2020-2028
8.4.2. South America Cluster Headache Market Value US$ Mn, By Drug Type, 2018-2030
8.4.3. South America Cluster Headache Market Value (US$ Mn), By Drug Type, Table, 2018-2030
8.4.4. South America Cluster Headache Market share (%), By Drug Type, Table, 2018-2030
8.5. South America Cluster Headache Market Outlook, By Route of Administration
8.5.1. South America Cluster Headache Market share % By Route of Administration, 2016-2020-2028
8.5.2. South America Cluster Headache Market Value US$ Mn, By Route of Administration, 2018-2030
8.5.3. South America Cluster Headache Market Value (US$ Mn), By Route of Administration, Table, 2018-2030
8.5.4. South America Cluster Headache Market share (%), By Route of Administration, Table, 2018-2030
8.6. South America Cluster Headache Market Outlook, By Distribution Channel
8.6.1. South America Cluster Headache Market share % By Distribution Channel, 2016-2020-2028
8.6.2. South America Cluster Headache Market Value US$ Mn, By Distribution Channel, 2018-2030
8.6.3. South America Cluster Headache Market Value (US$ Mn), By Distribution Channel, Table, 2018-2030
8.6.4. South America Cluster Headache Market share (%), By Distribution Channel, Table, 2018-2030
8.7. South America Cluster Headache Market Outlook, by Country
8.7.1. South America Cluster Headache Market share % by Country, 2016-2020-2028
8.7.2. South America Cluster Headache Market Value US$ Mn, By Country, 2018-2030
8.7.3. South America Cluster Headache Market Value (US$ Mn), By Country, Table, 2018-2030
8.7.4. South America Cluster Headache Market share (%), By Country, Table, 2018-2030

9. MEA Cluster Headache Market Overview
9.1. MEA Cluster Headache Market Value (US$ Mn), 2018-2030
9.2. MEA Cluster Headache Market Incremental Opportunity (US$ Mn), 2018-2030
9.3. MEA Cluster Headache Market Outlook, By Type
9.3.1. MEA Cluster Headache Market share % By Type, 2016-2020-2028
9.3.2. MEA Cluster Headache Market Value US$ Mn, By Type, 2018-2030
9.3.3. MEA Cluster Headache Market Value (US$ Mn), By Type, Table, 2018-2030
9.3.4. MEA Cluster Headache Market share (%), By Type, Table, 2018-2030
9.4. MEA Cluster Headache Market Outlook, By Drug Type
9.4.1. MEA Cluster Headache Market share % By Drug Type, 2016-2020-2028
9.4.2. MEA Cluster Headache Market Value US$ Mn, By Drug Type, 2018-2030
9.4.3. MEA Cluster Headache Market Value (US$ Mn), By Drug Type, Table, 2018-2030
9.4.4. MEA Cluster Headache Market share (%), By Drug Type, Table, 2018-2030
9.5. MEA Cluster Headache Market Outlook, By Route of Administration
9.5.1. MEA Cluster Headache Market share % By Route of Administration, 2016-2020-2028
9.5.2. MEA Cluster Headache Market Value US$ Mn, By Route of Administration, 2018-2030
9.5.3. MEA Cluster Headache Market Value (US$ Mn), By Route of Administration, Table, 2018-2030
9.5.4. MEA Cluster Headache Market share (%), By Route of Administration, Table, 2018-2030
9.6. MEA Cluster Headache Market Outlook, By Distribution Channel
9.6.1. MEA Cluster Headache Market share % By Distribution Channel, 2016-2020-2028
9.6.2. MEA Cluster Headache Market Value US$ Mn, By Distribution Channel, 2018-2030
9.6.3. MEA Cluster Headache Market Value (US$ Mn), By Distribution Channel, Table, 2018-2030
9.6.4. MEA Cluster Headache Market share (%), By Distribution Channel, Table, 2018-2030
9.7. MEA Cluster Headache Market Outlook, by Country
9.7.1. MEA Cluster Headache Market share % by Country, 2016-2020-2028
9.7.2. MEA Cluster Headache Market Value US$ Mn, By Country, 2018-2030
9.7.3. MEA Cluster Headache Market Value (US$ Mn), By Country, Table, 2018-2030
9.7.4. MEA Cluster Headache Market share (%), By Country, Table, 2018-2030

10. Company Profile
10.1. Competitive Index
10.2. Takeda Pharmaceutical Company Limited
10.2.1. Company Description
10.2.2. Product Types
10.2.3. Recent development
10.2.4. SWOT Analysis
10.2.5. Financial Performance
10.3. Sun Pharmaceutical Industries Ltd.
10.3.1. Company Description
10.3.2. Product Types
10.3.3. Recent development
10.3.4. SWOT Analysis
10.3.5. Financial Performance
10.4. Novartis AG
10.4.1. Company Description
10.4.2. Product Types
10.4.3. Recent development
10.4.4. SWOT Analysis
10.4.5. Financial Performance
10.5. Teva Pharmaceutical Industries Ltd.
10.5.1. Company Description
10.5.2. Product Types
10.5.3. Recent development
10.5.4. SWOT Analysis
10.5.5. Financial Performance
10.6. Allergan LLC
10.6.1. Company Description
10.6.2. Product Types
10.6.3. Recent development
10.6.4. SWOT Analysis
10.6.5. Financial Performance
10.7. Autonomic Technologies, Inc.
10.7.1. Company Description
10.7.2. Product Types
10.7.3. Recent development
10.7.4. SWOT Analysis
10.7.5. Financial Performance
10.8. ElectroCore Medical LLC
10.8.1. Company Description
10.8.2. Product Types
10.8.3. Recent development
10.8.4. SWOT Analysis
10.8.5. Financial Performance
10.9. Eli Lilly and Company
10.9.1. Company Description
10.9.2. Product Types
10.9.3. Recent development
10.9.4. SWOT Analysis
10.9.5. Financial Performance
10.10. Zosano Pharma
10.10.1. Company Description
10.10.2. Product Types
10.10.3. Recent development
10.10.4. SWOT Analysis
10.10.5. Financial Performance
10.11. AbbVie Inc
10.11.1. Company Description
10.11.2. Product Types
10.11.3. Recent development
10.11.4. SWOT Analysis
10.11.5. Financial Performance